HARROW, INC. — Director's Dealing 2017

Mar 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2017-03-09

Reporting Person: Kammer Robert J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-09	Common Stock	J	20000	—	Disposed	1069827	Direct

Footnotes

F1: On March 9, 2017, Dr. Kammer, transferred 20,000 shares of Imprimis Pharmaceuticals, Inc.'s common stock to a third party, in connection with a settlement agreement and previously settled lawsuit. As part of the settlement, Dr. Kammer transferred 20,000 shares of common stock and received no consideration.